Skip to content

Clinical trials

Completed Phase 1/2 Inflammation trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Phase: Phase 1/2 Status: Completed Clear all

55 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20041
20052
20063
20073
20081
20092
20112
20123
20136
20143
20157
20163
20173
20182
20193
20205
20233
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed55

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Lund University3
Kristianstad University2
Novartis2
University of Oslo2
Virginia Commonwealth University2
Biotectid GmbH1
Charite University, Berlin, Germany1
Children's Hospital Medical Center, Cincinnati1
Clearside Biomedical, Inc.1
Columbia University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation55
Alzheimer Disease3
Metabolic Syndrome3
Autoimmune Diseases2
Cardiovascular Diseases2
Diabetes Mellitus, Type 22
HIV Infections2
Heart Failure2
Insulin Resistance2
Myocardial Infarction2

Trials

Showing 1 to 25 of 55. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.